- Home
- CADL vs RXST Comparison
CADL vs RXST Comparison
Compare CADL & RXST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CADL
- RXST
- Stock Information
- Founded
- CADL 1999
- RXST 1997
- Country
- CADL United States
- RXST United States
- Employees
- CADL N/A
- RXST N/A
- Industry
- CADL Biotechnology: Pharmaceutical Preparations
- RXST Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- CADL Health Care
- RXST Health Care
- Exchange
- CADL Nasdaq
- RXST Nasdaq
- Market Cap
- CADL 339.8M
- RXST 307.3M
- IPO Year
- CADL 2021
- RXST 2021
- Fundamental
- Price
- CADL $4.47
- RXST $8.98
- Analyst Decision
- CADL Strong Buy
- RXST Hold
- Analyst Count
- CADL 7
- RXST 11
- Target Price
- CADL $19.43
- RXST $11.20
- AVG Volume (30 Days)
- CADL 652.0K
- RXST 733.4K
- Earning Date
- CADL 11-13-2025
- RXST 11-05-2025
- Dividend Yield
- CADL N/A
- RXST N/A
- EPS Growth
- CADL N/A
- RXST N/A
- EPS
- CADL N/A
- RXST N/A
- Revenue
- CADL N/A
- RXST $142,085,000.00
- Revenue This Year
- CADL N/A
- RXST N/A
- Revenue Next Year
- CADL N/A
- RXST $6.71
- P/E Ratio
- CADL N/A
- RXST N/A
- Revenue Growth
- CADL N/A
- RXST 10.75
- 52 Week Low
- CADL $3.93
- RXST $6.32
- 52 Week High
- CADL $14.60
- RXST $47.89
- Technical
- Relative Strength Index (RSI)
- CADL 32.75
- RXST 47.59
- Support Level
- CADL $4.46
- RXST $9.45
- Resistance Level
- CADL $4.72
- RXST $10.12
- Average True Range (ATR)
- CADL 0.27
- RXST 0.78
- MACD
- CADL -0.06
- RXST -0.01
- Stochastic Oscillator
- CADL 5.19
- RXST 34.89
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
About RXST RxSight Inc.
RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.